BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30334726)

  • 1. Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan.
    Nishimura T; Ota M; Mori M; Hasegawa N; Kawabe H; Kato S
    Emerg Infect Dis; 2018 Nov; 24(11):2111-2113. PubMed ID: 30334726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The annual risk of tuberculosis infection in newly hired researchers and healthcare workers using interferon-gamma release assay in Japan.
    Nishimura T; Ota M; Mori M; Takano Y; Fujiwara H; Uwamino Y; Uno S; Hasegawa N
    J Infect Chemother; 2020 Aug; 26(8):818-822. PubMed ID: 32327332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Tuberculosis Incidence among Interferon-Gamma Release Assay-Positive Individuals with Latent Tuberculosis Infection and Fibrotic Lesions in a Vulnerable Urban Population in Osaka City, Japan, 2015-2021.
    Komukai J; Matsumoto K; Fukushima W; Kudoh S
    Jpn J Infect Dis; 2024 Jan; 77(1):21-24. PubMed ID: 37779028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
    Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
    Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of interferon-γ release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation.
    Ishikawa S; Igari H; Akutsu N; Tsuyuzaki M; Aoyama H; Hasegawa M; Otsuki K; Maruyama M; Saigo K; Suzuki K; Yamagishi F
    J Infect Chemother; 2017 Jul; 23(7):468-473. PubMed ID: 28438462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Latent Tuberculosis Infection.
    Lardizabal AA; Reichman LB
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of latent tuberculosis infection among laboratory personnel at a University Hospital in Eastern Saudi Arabia using an interferon gamma release assay.
    Hassan MI; Diab AE
    J Infect Public Health; 2014; 7(4):289-95. PubMed ID: 24835036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma release assays and the diagnosis of tuberculosis: have they found their place?
    Darby J; Black J; Buising K
    Intern Med J; 2014 Jul; 44(7):624-32. PubMed ID: 25041769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
    Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
    J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.